Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUsed Wegovy pens cannot go in your household recycling bin. Because each pre-filled pen contains needle components and traces of a prescription medicine, the correct disposal route in the UK is a sharps container, not the blue or green bin on your doorstep. Here is what official UK guidance says, and what to do in practice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The NHS medicines information page for semaglutide is explicit: used injection pens should be disposed of in a sharps bin, not placed in household waste or recycling. This is not a technicality. Each Wegovy pen houses a needle that poses a puncture risk to waste handlers, and the cartridge retains traces of semaglutide even after the dose is delivered. Landfill or kerbside recycling streams are not designed to manage either hazard.
It is a point worth knowing before you start treatment. A question that comes up on the Wegovy treatment overview is what happens to the packaging once a course is underway. The short answer: the outer cardboard box and paper leaflet can go into standard recycling, the used pen itself cannot.
One practical note, if you order by 12pm, your pen arrives the next working day via DPD. Factor in collection of your sharps bin at the same time, so everything is ready when treatment begins rather than after the first injection.
For most people in England, the simplest route is a council-provided sharps collection service. Local authorities in England have a legal duty under the Environmental Protection Act to collect clinical waste from households where medicines have been prescribed. You can request a yellow-lidded sharps bin from your GP surgery, your local pharmacy, or directly through your council; once full, the same council arranges collection, usually free. The guidance for patients starting on a single starter pen applies here too: even one pen warrants a proper sharps bin rather than an improvised container.
If you are travelling and need interim storage, most pharmacies will supply a small travel sharps container on request, and the guidance on travelling with Wegovy covers what to do if you are abroad or away from home when a pen is finished. The key principle remains the same wherever you are: the pen goes into a rigid, puncture-resistant container, not loose in a bag.
A one-litre sharps container is suitable for most patients on a standard once-weekly schedule. Each Wegovy pen is single-use, so over a four-week supply you will typically use one pen. A litre container holds considerably more than that, making it practical for several months of treatment before a collection is needed.
Beyond disposal, there is a genuine recycling option. Novo Nordisk operates a circular-economy scheme that accepts used Wegovy pens by freepost in the UK. Patients request a prepaid return envelope, seal the used pen inside (with the outer cap on and the needle safely inside), and post it back. The returned pens are processed at a licensed facility: the plastic components are separated and recovered as material for secondary manufacturing, diverting them from incineration or landfill.
Details of the scheme, including how to request return envelopes, are available directly from Novo Nordisk UK (novonordisk.co.uk). It is separate from the council sharps collection service and does not replace it for pens that still contain a needle; the postal scheme is for pens that have been fully used and where the needle has been removed by a healthcare professional or is enclosed within the device. If you are unsure whether your specific pen format qualifies, your dispensing pharmacy is the right place to ask.
The Wegovy pen guide explains the device format in more detail, which matters when you are working out whether the postal scheme applies to your pen type.
Wegovy pens come with a needle that must be removed after each injection and placed in the sharps bin immediately, before anything else. The pen then gets its outer cap replaced and can go into the same sharps bin, or be set aside for the postal recycling scheme if you prefer.
Changing the needle after every injection is not optional hygiene: a used needle blunts quickly, increasing injection discomfort, and leaving a needle attached creates a pressure risk if the pen temperature changes (for instance, moving from a cold fridge to a warm room). The information on Wegovy pen volumes and fill levels explains why the pen is designed as it is, which makes the needle-change instruction easier to understand in context.
If you are still working out the full picture of what Wegovy treatment involves (including costs, eligibility, and what is included in a private consultation) the Wegovy pricing overview is a clear starting point. Treatment at nume is prescription-only, assessed by a GPhC-registered prescriber, and starts with a free consultation. Disposal is one small part of using these medicines safely; the prescriber's role is to make sure the whole picture is right for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.